Physician profile
Shreya R Parikh
NPI 1437488806
$139,023.68
in general payments reported to CMS, 2019-2025
59 companies · $18K in 2025
The $18K reported for 2025 was more than what 92% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $18K · 2021: $8,706 · 2022: $12K · 2023: $17K · 2024: $17K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $16K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Consulting Fee: $3,350 · Travel and Lodging: $2,438 · Gift: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,262.50 |
| Food and Beverage | $16,058.02 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,156.00 |
| Consulting Fee | $3,350.00 |
| Travel and Lodging | $2,437.66 |
| Gift | $178.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $39,185.77 | 2019-2025 | Freestyle Libre 3 |
| Valeritas, INC. | $29,107.40 | 2019 | |
| Tandem Diabetes Care, INC. | $21,149.47 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $11,747.16 | 2019-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Mannkind Corporation | $6,287.33 | 2019-2025 | V-Go, Afrezza |
| Ascensia Diabetes Care US INC. | $3,983.84 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $3,870.52 | 2019-2025 | Farxiga, Lokelma |
| Novo Nordisk INC | $3,405.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Zealand Pharma US, INC. | $2,509.65 | 2020-2022 | |
| Lilly USA, LLC | $2,426.17 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Senseonics, Incorporated | $2,017.00 | 2020-2025 | Eversense |
| Amgen INC. | $1,490.29 | 2019-2025 | Evenity, Prolia, Prolia |
| Amarin Pharma, INC. | $1,096.23 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $1,088.13 | 2019-2025 | |
| Insulet Corporation | $1,085.63 | 2019-2025 | Omnipod |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $1,014.86 | 2019-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $992.77 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $671.80 | 2022-2025 | |
| Abbvie INC. | $578.18 | 2019-2025 | |
| Corcept Therapeutics | $398.06 | 2024-2025 | Korlym |
| Embecta Corp. | $368.68 | 2024-2025 | Bd Nano 2nd Gen Pen Needle |
| Merck Sharp & Dohme LLC | $345.98 | 2019-2023 | Steglatro |
| Intuity Medical INC | $327.71 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Xeris Pharmaceuticals, INC. | $296.86 | 2021-2024 | Gvoke Hypopen, Recorlev |
| Ascendis Pharma Endocrinology INC | $294.05 | 2025 | Yorvipath |
| Cequr Corporation | $286.98 | 2021-2025 | Cequr Simplicity |
| Ibsa Pharma INC. | $283.44 | 2019-2025 | Tirosint, Licart, Flector |
| Horizon Therapeutics Plc | $253.25 | 2020-2023 | Tepezza |
| Beta Bionics, INC. | $237.11 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Bigfoot Biomedical INC | $231.33 | 2021-2022 | |
| Medtronic, INC. | $214.27 | 2021-2025 | Minimed 780g, Intellis Adaptivestim, Inpen Smart Insulin Delivery System |
| Amneal Pharmaceuticals LLC | $213.06 | 2020-2025 | Unithroid |
| Janssen Pharmaceuticals, INC | $198.81 | 2019-2020 | |
| Antares Pharma, INC. | $161.86 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Amphastar Pharmaceuticals, INC. | $142.19 | 2023-2025 | Baqsimi |
| Kyowa Kirin, INC. | $135.37 | 2024-2025 | Crysvita |
| Becton, Dickinson and Company | $100.53 | 2019 | |
| Sequel Med Tech, LLC | $96.58 | 2025 | Twiist |
| Currax Pharmaceuticals LLC | $85.29 | 2020-2023 | Contrave |
| Esperion Therapeutics, INC. | $70.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $69.41 | 2022-2023 | |
| Verity Pharmaceuticals INC. | $51.01 | 2024-2025 | Tlando |
| Alexion Pharmaceuticals, INC. | $46.69 | 2022-2025 | Strensiq |
| Eisai INC. | $42.69 | 2019 | |
| Companion Medical, INC. | $39.41 | 2019 | |
| Acella Pharmaceuticals, LLC | $36.56 | 2024-2025 | NP Thyroid 60 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.75 | 2022 | |
| Lifescan, INC. | $33.66 | 2019 | |
| Tolmar, INC. | $32.91 | 2023-2024 | |
| Shire North American Group INC | $30.59 | 2019 | |
| Endo Pharmaceuticals INC. | $30.30 | 2020-2021 | |
| Astellas Pharma US INC | $26.37 | 2023 | Veozah |
| Pfizer INC. | $19.35 | 2022 | |
| Recordati_rare_diseases_inc. | $18.61 | 2024 | Isturisa, Signifor Lar |
| Roche Diabetes Care, INC. | $17.68 | 2019 | |
| Vivus LLC | $14.59 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $13.49 | 2019 | |
| Althera Pharmaceuticals LLC | $11.67 | 2021 | |
| Theracosbio, LLC | $5.36 | 2024 | Brenzavvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shreya Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.